アルフレッサ ファーマ株式会社

Nakashima Shigeru Shoten was founded as an importer and distributor of pharmaceuticals and medical devices in Manila, the Republic of Philippines.

Started business as a pharmaceuticals developer and manufacturer under the name of Sansho Co., Ltd.

医薬品の開発と製造を目的に三生製薬株式会社として創業

The business expanded due to the success of the liver oil tablet, 'Haliva.'

フィリピン、マニラ市に、医薬品・医療機器等の現地輸入販売業「中島茂商店」を創立

Incorporated Osaka Office into Nakashima Shigeru Shoten.

大阪支店を「株式会社中島茂商店」に改組設立

Corporate name changed to Nippon Shoji Kaisha, Ltd.

Started full-scale production of pharmaceuticals for Eisai Co., Ltd.

Became a subsidiary of Eisai Co., Ltd.

Eisai Co., Ltd. released the medicine for iron-deficiency, anemia, developed by ourself.

Acquired an authorization of contract manufacturing from Eisai Co., Ltd.

Transitioned into a large company under commercial law based on increased capital.

Started production of barrier-free medicines, marketed by Elmed Eisai Co., Ltd. Acquired a manufacturing authorization of liquid-, ointment-, and cream-form medicines from Eisai Co., Ltd.

中国山東省に青島耐絲克医材有限公司を設立

Nippon Shoji and Showa Pharmaceuticals merged to form AZWELL Inc.

本社を群馬県太田市世良田町に移転しました（旧称：新田郡大島町）。

群馬県太田市世良田町への全社移転を完了しました。会社名をサンノバ株式会社に変更しました。

Obtained the ISO 14001 certification.

日本商事株式会社と昭和薬品株式会社が合併し、株式会社アズウェル誕生

AZWELL Inc. and Fukujin Co., Ltd. established Alfresa Holdings Corporation through stock transfer.

福神株式会社と経営統合し、共同持株会社アルフレッサ ホールディングス株式会社を設立

Alfresa Pharma Corporation was established.

Established new drainage treatment facilities.

Ibaraki Research Center, Okayama Plant, and Chiba Plant obtained the ISO13485:2003 certification.

Took over the Akita Plant of Daiichi Sankyo Propharma Co., Ltd., and establishes Alfresa Fine Chemical Corporation.

Sannova Co., Ltd. became a wholly owned subsidiary of Alfresa Holdings Corporation.

Alfresa Pharma Corporation and Sannova Co., Ltd. merges their operations.